OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double‐Blind Randomized Controlled Trial
Thomas M. MacDonald, Bryan Williams, David J. Webb, et al.
Journal of the American Heart Association (2017) Vol. 6, Iss. 11
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams, Giuseppe Mancia, Wilko Spiering, et al.
European Heart Journal (2018) Vol. 39, Iss. 33, pp. 3021-3104
Open Access | Times Cited: 8813

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Heart Journal (2021) Vol. 42, Iss. 34, pp. 3227-3337
Open Access | Times Cited: 4328

2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams, Giuseppe Mancia, Wilko Spiering, et al.
Journal of Hypertension (2018) Vol. 36, Iss. 10, pp. 1953-2041
Open Access | Times Cited: 2578

Arterial hypertension in adults. Clinical guidelines 2020
Zhanna Kobalava, А. О. Конради, С. В. Недогода, et al.
Russian Journal of Cardiology (2020) Vol. 25, Iss. 3, pp. 3786-3786
Open Access | Times Cited: 483

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Journal of Preventive Cardiology (2021) Vol. 29, Iss. 1, pp. 5-115
Open Access | Times Cited: 382

2024 ESC Guidelines for the management of elevated blood pressure and hypertension
John W. McEvoy, Cian P. McCarthy, Rosa María Bruno, et al.
European Heart Journal (2024)
Closed Access | Times Cited: 322

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
Bryan Williams, Thomas M. MacDonald, S. V. Morant, et al.
The Lancet Diabetes & Endocrinology (2018) Vol. 6, Iss. 6, pp. 464-475
Open Access | Times Cited: 232

European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack
Jesse Dawson, Yannick Béjot, Louisa Christensen, et al.
European Stroke Journal (2022) Vol. 7, Iss. 3, pp. I-XLI
Open Access | Times Cited: 118

Role of Artificial Intelligence in Revolutionizing Drug Discovery
Ashfaq Ur Rehman, Mingyu Li, Binjian Wu, et al.
Fundamental Research (2024)
Open Access | Times Cited: 24

2024 Clinical practice guidelines for Hypertension in adults
Ж. Д. Кобалава, А. О. Конради, С. В. Недогода, et al.
Russian Journal of Cardiology (2024) Vol. 29, Iss. 9, pp. 6117-6117
Open Access | Times Cited: 19

European stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic stroke
Joanna M. Wardlaw, Hugues Chabriat, Frank–Erik de Leeuw, et al.
European Stroke Journal (2024) Vol. 9, Iss. 1, pp. 5-68
Open Access | Times Cited: 18

Device-based therapies for arterial hypertension
Lucas Lauder, Michel Azizi, Ajay J. Kirtane, et al.
Nature Reviews Cardiology (2020) Vol. 17, Iss. 10, pp. 614-628
Closed Access | Times Cited: 104

Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertension
Abdul Salam, Raju Kanukula, Emily Atkins, et al.
Journal of Hypertension (2019) Vol. 37, Iss. 9, pp. 1768-1774
Closed Access | Times Cited: 83

2019 Chinese guideline for the management of hypertension in the elderly.
Qi Hua, Li Fan, Jing Li
PubMed (2019) Vol. 16, Iss. 2, pp. 67-99
Closed Access | Times Cited: 79

Guía práctica sobre el diagnóstico y tratamiento de la hipertensión arterial en España, 2022. Sociedad Española de Hipertensión - Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA)
Manuel Gorostidi, Teresa Gijón‐Conde, Àngels Sierra, et al.
Hipertensión y Riesgo Vascular (2022) Vol. 39, Iss. 4, pp. 174-194
Closed Access | Times Cited: 62

Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
Revista Española de Cardiología (2022) Vol. 75, Iss. 5, pp. 429.e1-429.e104
Closed Access | Times Cited: 47

From understanding diseases to drug design: can artificial intelligence bridge the gap?
Anju Choorakottayil Pushkaran, Alya A. Arabi
Artificial Intelligence Review (2024) Vol. 57, Iss. 4
Open Access | Times Cited: 15

Low-Dose Triple-Pill vs Standard-Care Protocols for Hypertension Treatment in Nigeria
Dike Ojji, Abdul Salam, Mahmoud U. Sani, et al.
JAMA (2024)
Closed Access | Times Cited: 9

Novel pharmacological approaches to lowering blood pressure and managing hypertension
Matthew Sayer, David J. Webb, Neeraj Dhaun
Nature Reviews Cardiology (2025)
Closed Access | Times Cited: 1

Impact of single-pill combination therapy on adherence, blood pressure control, and clinical outcomes: a rapid evidence assessment of recent literature
Konstantinos Tsioufis, Reinhold Kreutz, Georgia Sykara, et al.
Journal of Hypertension (2020) Vol. 38, Iss. 6, pp. 1016-1028
Open Access | Times Cited: 56

Prevalence, awareness, treatment, and control of hypertension in older people: results from the population-based KORA-age 1 study
Samuel Muli, Christa Meisinger, Margit Heier, et al.
BMC Public Health (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 53

Standardized treatment to improve hypertension control in primary health care: The HEARTS in the Americas Initiative
Donald J. DiPette, Kenneth Goughnour, Eric Zúñiga, et al.
Journal of Clinical Hypertension (2020) Vol. 22, Iss. 12, pp. 2285-2295
Open Access | Times Cited: 43

Two‐drug fixed‐dose combinations of blood pressure‐lowering drugs as WHO essential medicines: An overview of efficacy, safety, and cost
Abdul Salam, Mark D. Huffman, Raju Kanukula, et al.
Journal of Clinical Hypertension (2020) Vol. 22, Iss. 10, pp. 1769-1779
Open Access | Times Cited: 40

Caffeic acid, a dietary polyphenol, as a promising candidate for combination therapy
Swastika Maity, Manas Kinra, Madhavan Nampoothiri, et al.
Chemical Papers (2021) Vol. 76, Iss. 3, pp. 1271-1283
Open Access | Times Cited: 36

Page 1 - Next Page

Scroll to top